ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Embrex

Embrex (EMBX)

0.00
0.00
(0.00%)
Closed November 28 4:00PM
0.00
0.00
(0.00%)

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
-
Bid
-
Ask
-
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
-
Open
-
Last Trade
Last Trade Time
Average Volume (3m)
-
Financial Volume
-
VWAP
-

EMBX Latest News

Pfizer Animal Health Completes Acquisition of Embrex, Inc.

NEW YORK, Jan. 19 /PRNewswire-FirstCall/ -- Pfizer Animal Health, a division of Pfizer Inc (NYSE:PFE) today announced the completion of its acquisition of Embrex, Inc. (NASDAQ:EMBX), an...

Embrex Sets January 19, 2007, for Shareholder Meeting to Approve Merger With Pfizer Inc.

RESEARCH TRIANGLE PARK, N.C., Dec. 12 /PRNewswire-FirstCall/ -- Embrex(R), Inc., The In Ovo Company(R), (NASDAQ:EMBX) announced that a special meeting of its shareholders will be held on January...

Pfizer Animal Health Agrees to Acquire Embrex, Inc., the Leader in 'In Ovo' Poultry Vaccine-Delivery Technology

NEW YORK and RESEARCH TRIANGLE PARK, N.C., Nov. 15 /PRNewswire-FirstCall/ -- Pfizer Animal Health, a division of Pfizer Inc (NYSE:PFE) has agreed to acquire Embrex, Inc. (NASDAQ:EMBX), an...

Embrex Reports Third-Quarter 2006 Financial Results

RESEARCH TRIANGLE PARK, N.C., Nov. 6 /PRNewswire-FirstCall/ -- Embrex(R), Inc., The In Ovo Company(R), (NASDAQ:EMBX) announces financial results for the third quarter ended September 30, 2006...

Embrex Announces Third Quarter 2006 Financial Results Release on November 6, 2006 and Conference Call on November 7, 2006

RESEARCH TRIANGLE PARK, N.C., Oct. 20 /PRNewswire-FirstCall/ -- Embrex(R), Inc., The In Ovo Company(R), (NASDAQ:EMBX) announced Embrex management intends to file its Third Quarter 2006 Form 10-Q...

Embrex Reports Second-Quarter 2006 Financial Results

RESEARCH TRIANGLE PARK, N.C., Aug. 7 /PRNewswire/ -- Embrex(R), Inc., The In Ovo Company(R), (NASDAQ:EMBX) announces financial results for the second quarter ended June 30, 2006. Highlights...

Embrex and Shenzhen Neptunus Interlong, P.R. China, Collaborate on Installation and Sale of Devices for Human Influenza Vaccine

RESEARCH TRIANGLE PARK, N.C., Aug. 1 /PRNewswire-FirstCall/ -- Embrex, Inc., The In Ovo Company(R), (NASDAQ:EMBX) has recently delivered to Shenzhen Neptunus Interlong Bio-technique Co. Ltd...

Embrex Announces Second Quarter 2006 Financial Results Release and Conference Call

RESEARCH TRIANGLE PARK, N.C., July 17 /PRNewswire-FirstCall/ -- Embrex(R), Inc., The In Ovo Company(R), (NASDAQ:EMBX) announced Embrex management intends to file its Second Quarter 2006 Form...

Embrex Reports First-Quarter 2006 Financial Results

RESEARCH TRIANGLE PARK, N.C., May 8 /PRNewswire-FirstCall/ -- Embrex(R), Inc., The In Ovo Company(R), (NASDAQ:EMBX) announces financial results for the first-quarter ended March 31, 2006...

Embrex Announces First Quarter 2006 Financial Results Release and Conference Call

Embrex(R), Inc., The In Ovo Company(R), (Nasdaq:EMBX) announced Embrex management intends to file its First Quarter 2006 Form 10-Q and issue its financial press release on Monday, May 8, 2006...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
VCIGVCI Global Ltd
$ 4.1092
(129.56%)
257.58M
IDAIT Stamp Inc
$ 0.835
(128.77%)
374.4M
WAITop KingWin Ltd
$ 0.43
(79.17%)
121.92M
HWHHWH International Inc
$ 0.918
(62.48%)
32.27M
PROCProcaps Group SA
$ 2.149
(58.01%)
211.74k
PGHLPrimega Group Holdings Ltd
$ 1.6455
(-98.47%)
43.2M
OTLKOutlook Therapeutics Inc
$ 1.695
(-65.34%)
61.98M
IMGCIMG Inc
$ 0.8831
(-44.81%)
5.22M
KDLYKindly MD Inc
$ 1.075
(-43.12%)
3.54M
HAOHaoxi Health Technology Ltd
$ 0.13
(-36.59%)
36.86M
IDAIT Stamp Inc
$ 0.835
(128.77%)
374.4M
VCIGVCI Global Ltd
$ 4.1092
(129.56%)
257.58M
NVDANVIDIA Corporation
$ 135.34
(-1.15%)
226.41M
WAITop KingWin Ltd
$ 0.43
(79.17%)
121.92M
MARAMARA Holdings Inc
$ 26.915
(7.79%)
87.94M

Discussion

View Full Feed
threewheeler threewheeler 9 minutes ago
KRTL waking up, just had news first in long time and the SS is fantastic, more news expected per twitter (X) zero toxic, zero dilution .10s then quarters FDA approved not scam P&D Share Structure
Market Cap Market Cap
3,058,645
11/27/2024
Authorized Shares
1,000,00
DTC KRTL
gp22 gp22 11 minutes ago
$MTEK & $MOB: Last two microfloat "Donald Trump AI Drone Effect" stocks yet to rip. Both have solid military & civilian contracts in place. Easy targets for Friday & next week. Volume & price have been elevating this week.
MOB MTEK
gp22 gp22 12 minutes ago
$MTEK & $MOB: Last two microfloat "Donald Trump AI Drone Effect" stocks yet to rip. Both have solid military & civilian contracts in place. Easy targets for Friday & next week. Volume & price have been elevating this week.
MOB MTEK
Maknmoney78 Maknmoney78 14 minutes ago
I'm with you KarlAi, these triple zeros are cheap for any otc stock that has any potential at all to come out with acquisition news and not just one acquisition but four.  That has pennyland written all over it.... and depending on what kind of  acquisitions they could lead to even more.  Profits ca
ICTY
Trooperstocks Trooperstocks 15 minutes ago
SGTM The company's subsidiary, SGTM-VRM, LLC, is efficient in logistics capabilities and ensuring operations.
SGTM
ironhammer ironhammer 15 minutes ago
hear is a stock that started on the OTC there are several more in this catigory
Apple (AAPL – NASDAQ)
Rewind to the early 2000s and Apple was trading at less than a dollar per share. Today, Apple is trading at $148, even after several forward splits. Venture into public anywhere in t
AAPL
learningcurve2020 learningcurve2020 18 minutes ago
Hey Ex, they deleted my reply to you for some reason. 
NWBO
Lykiri Lykiri 19 minutes ago
Yes, that's correct.(80 mg tablet)
Iqirvo was granted U.S. FDA accelerated approval in June 2024, EU conditional approval by the EMA in September 2024 and UK Medicines and Healthcare products Regulatory Agency (MHRA) approval in October 2024, for the treatment of primary biliary cholangitis (
NWBO
threewheeler threewheeler 20 minutes ago
KRTL waking up, just had news first in long time and the SS is fantastic, more news expected per twitter (X) zero toxic, zero dilution .10s then quarters FDA approved not scam P&D Share Structure
Market Cap Market Cap
3,058,645
11/27/2024
Authorized Shares
1,000,00
DTC KRTL
LTR LTR 21 minutes ago
I notice that Phunware stock did not get a bump from the good legal news. That is interesting. I would think that news would give a stock a lift, at list I was hoping so for our sake.
NWBO
crazy horse 0 crazy horse 0 23 minutes ago
TY and likewise

Best wishes to you and everyone on this board!
MartinLutherKing MartinLutherKing 24 minutes ago
ELAB🚀🚀🚀 Short squeeze breakout news coming
ELAB
crazy horse 0 crazy horse 0 24 minutes ago
TY Took a day off need it
Royal Dude Royal Dude 25 minutes ago
Always thought you were a sick SOB
COOP
3331 3331 25 minutes ago
Watch and learn chump.
DewDiligence DewDiligence 25 minutes ago
ENTA’s pro forma net cash @9/30/24=$276.8M—excluding balance-sheet “debt” relating to ENTA’s deferred-royalty obligations, which is a GAAP artifact rather than an actual debt instrument.*

The $276.8M figure, which declined $26.3M since 6/30/24, consists of the net current assets on t
ENTA
DewDiligence DewDiligence 27 minutes ago
ENTA’s fully-diluted share count @9/30/24=26.99M—a decrease of 0.05M shares since 6/30/24.

The 26.99M figure consists of: 21.19 basic shares on the 9/30/24 balance sheet (https://www.sec.gov/ix?doc=/Archives/edgar/data/0001177648/000095017024131260/enta-20240930.htm page F-4); and 5.8
ENTA
arizona1 arizona1 28 minutes ago
This is great.

https://cdn.bsky.app/img/feed_thumbnail/plain/did:plc:vocg5apjrlm7dfptvy6qbrfy/bafkreiagymjehtbpnyb3o3cvgazbbnybw56kuwxbveerlw2xrrj2hym6ee@jpeg

https://bsky.app/profile/briantylercohen.bsky.social/post/3lbvkw365v22i
MartinLutherKing MartinLutherKing 28 minutes ago
SAVA$$ ELAB🚀🚀RNAZ🚀🚀 Micro-Rna First of its class nobel prize clinical trials with FDA
ELAB RNAZ
delerious1 delerious1 29 minutes ago
So with more than 12,000 stocks trading over the counter everything that NBRI has done to date makes perfect sense....the mines, the Mill, the partnerships and all the many contacts that the company principals have made over the years.....looks like a win/win to me....I don't buy the FUD, not on thi
NBRI
nagoya1 nagoya1 29 minutes ago
I vote for your non vote. Lol
Fnma
FNMA
StocktonCA StocktonCA 30 minutes ago
From Stockton, left years ago, some fam is still there :)
IQST
Saving Grace Saving Grace 30 minutes ago
HYMC STOCK 📈🚨 HYCROFT MINING STOCK SHORT SQUEEZE PATTERN 😱💥🚀 HYMC STOCK ANALYSIS PREDICTIONS 2024 🥷📈

https://www.youtube.com/watch?v=1CUB-EP4ex8
HYMC
Giovanni Giovanni 31 minutes ago
Thank you



BioAdaptives, Inc. Announces Institutional Review Board Approval of a Human Clinical Trial for Zeranovia™



LAS VEGAS, Nov. 25, 2024 (GLOBE NEWSWIRE) -- via IBN – BioAdaptives Inc. (OTC: BDPT) received approval today for a human
GLP
Welcome2Pinkyland Welcome2Pinkyland 31 minutes ago
Tell us about capping fees. Are they forever, or longer?
PDGO

Your Recent History

Delayed Upgrade Clock